Biohaven Ltd (NYSE:BHVN)
$ 39.33 0.61 (1.58%) Market Cap: 3.47 Bil Enterprise Value: 3.17 Bil PE Ratio: 0 PB Ratio: 10.66 GF Score: 21/100

Q3 2020 Biohaven Pharmaceutical Holding Company Ltd Earnings Call Transcript

Nov 09, 2020 / 01:30PM GMT
Operator

Greetings, and welcome to Biohaven Pharmaceuticals third quarter earnings call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Cliff Bechtold, Chief Operating Officer.

Clifford Bechtold
Biohaven Pharmaceutical Holding Company Ltd. - President & GM of Biohaven Ireland and Chief Compliance Officer

Thank you, and welcome to the Biohaven's Third Quarter 2020 Earnings Call. Speaking on today's call are Dr. Vlad Coric, our Chief Executive Officer; Jim Engelhart, Chief Financial Officer; BJ Jones, our Chief Commercial Officer; and Dr. Elyse Stock, our Chief Medical Officer.

Earlier this morning, we issued a press release announcing the third quarter 2020 highlights. A copy of this press release can be found on our website at biohavenpharma.com, and we will file our Form 10-Q later today.

Before we begin, let me remind everyone that today's discussion contains forward-looking statements based on the environment as we currently see it and include risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot